Donatella Santini

Papers

1

Total Citations

121

H-Index

1

About

Donatella Santini is a leading figure in pancreatic surgery, whose work has fundamentally shaped the debate on minimally invasive approaches for cancer. Her research centers on surgical oncology, with a specific focus on the safety and efficacy of laparoscopic and robotic techniques for pancreatic malignancies. Santini’s most impactful contribution is her leadership in the landmark DIPLOMA trial, an international randomized non-inferiority study comparing minimally invasive distal pancreatectomy (MIDP) to open surgery for resectable pancreatic cancer. This pivotal 2023 paper, with over 120 citations, provided crucial evidence that MIDP is oncologically safe, addressing long-standing concerns about its use in cancer patients. By demonstrating comparable outcomes, her work has helped establish MIDP as a viable standard option, potentially reducing recovery times without compromising survival. Santini’s rigorous clinical research has directly influenced international surgical guidelines, making her a key voice in the movement toward less invasive cancer care. Her contributions continue to guide surgeons and reassure patients, cementing her reputation as a pioneer in evidence-based pancreatic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
121
Total Citations
121
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial
121 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 91

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago